Clearbridge Investments, LLC Eagle Pharmaceuticals, Inc. Transaction History

Clearbridge Investments, LLC

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2020 Aug 14, 2020	SELL	$43.24 - $55.02 $25,079 - $31,911	-580 Closed	0 $0
Q1 2020 May 15, 2020	SELL	$34.37 - $60.07 $687 - $1,201	-20 Reduced 3.33%	580 $27,000
Q4 2019 Feb 14, 2020	BUY	$54.32 - $64.31 $32,592 - $38,586	600 New	600 $36,000

8.6M

100

Ticker EGRX
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 13,015,900
Market Cap $7.81M
Description
Eagle Pharmaceuticals, Inc., a pharmaceutical company, focuses on developing and commercializing product candidates to treat diseases of the central nervous system or metabolic critical care, and oncology in the United States. The company offers Ryanodex for malignant hyperthermia; and Belrapzo and Bendeka for chronic lymphocytic leukemia and in...

Get notified when there are updates to the investment portfolio of Clearbridge Investments, LLC, based on Form 13F filings with the SEC.

Stay updated on Clearbridge Investments, LLC with notifications on news.